ANTHONY EATON: Open Payments
NPI 1831193101 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 123 payments from 26 companies in 2025. Trend: 2023 $94 · 2024 $2,275 · 2025 $2,449
Food & beverage: $2,449
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $442 |
| PFIZER INC. | 13 | $268 |
| AstraZeneca Pharmaceuticals LP | 12 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $175 |
| Lilly USA, LLC | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 7 | $132 |
| Lundbeck LLC | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
Products named: UBRELVY, JARDIANCE, REXULTI, VRAYLAR, ELIQUIS, AUSTEDO XR, CAPLYTA, XIFAXAN.
Industry payments across MA — which companies pay providers there.
